Gelatinases, endonuclease and Vascular Endothelial Growth Factor during development and regression of swine luteal tissue

BMC Developmental Biology

Volumn 6, Issue , 2006, Pages

  Ribeiro, Luciana Andrea ^a   Turba, Maria Elena ^a   Zannoni, Augusta ^a   Bacci, Maria Laura ^a   Forni, Monica ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; ENDONUCLEASE; GELATINASE; GELATINASE A; GELATINASE B; MAGNESIUM; MATRIX METALLOPROTEINASE; VASCULOTROPIN; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; CORPUS LUTEUM; ESTRUS CYCLE; EXPERIMENTAL ANIMAL; EXTRACELLULAR MATRIX; LUTEOLYSIS; MITOSIS; NONHUMAN; OVULATION; PROTEIN EXPRESSION; SWINE; AGING; ANIMAL; FEMALE; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PHYSIOLOGY; VASCULARIZATION;

SUS SCROFA;

AGING; ANIMALS; CORPUS LUTEUM; ENDONUCLEASES; FEMALE; GELATINASES; MATRIX METALLOPROTEINASES; NEOVASCULARIZATION, PHYSIOLOGIC; SWINE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33845477490     PISSN: None     EISSN: 1471213X     Source Type: Journal    
DOI: 10.1186/1471-213X-6-58     Document Type: Article

References (52)

1. Plendl J: Angiogenesis and vascular regression in the ovary. Anat Histol Embryol 2000, 29:257-266.
2. Christenson LK, Stouffer RL: Proliferation of microvascular endothelial cells in the primate corpus luteum during the menstrual cycle and simulated early pregnancy. Endocrinology 1996, 137:367-374.
3. Fraser HM, Duncan WC: Vascular morphogenesis in the primate ovary. Angiogenesis 2005, 8:101-116.
4. Mattioli M, Barboni B, Turriani M, Galeati G, Zannoni A, Castellani G, Berardinelli P, Scapolo PA: Follicle activation involves vascular endothelial growth factor production and increased blood vessel extension. Biol Reprod 2001, 65:1014-1019.
5. Ribeiro LA, Bacci ML, Seren E, Tamanini C, Forni M: Characterization and differential expression of Vascular Endothelial Growth Factor isoforms and receptors in swine corpus luteum throughout estrous cycle. Mol Reprod Dev 2007 , 74:163-71.
6. Moses MA: The regulation of neovascularization by matrix metalloproteinases and their inhibitors. Stem Cells 1997, 15:180-189.
7. Curry TE Jr, Osteen KG: The matrix metalloproteinase system: changes, regulation, and impact throughout the ovarian and uterine reproductive cycle. Endocr Rev 2003, 24:428-465.
8. Curry TE Jr, Osteen KG: Cyclic changes in the matrix metalloproteinase system in the ovary and uterus. Biol Reprod 2001, 64:1285-1296.
9. Bacci ML, Barazzoni AM, Forni M, Lalatta Costerbosa G: In situ detection of apoptosis in regressing corpus luteum of pregnant sow: evidence of an early presence of DNA fragmentation. Domest Anim Endocrinol 1996, 13:361-372.
10. Forni M, Zannoni A, Tamanini C, Bacci ML: Opposite regulation of clusterin and LH receptor in the swine corpus luteum during luteolysis. Reprod Nutr Dev 2003, 43:517-525.
11. Diaz FJ, Wiltbank MC: Acquisition of luteolytic capacity involves differential regulation by prostaglandin F2-alpha of genes involved in progesterone biosynthesis in the porcine corpus luteum. Domest Anim Endocrinol 2005, 28:172-89.
12. Neuvians TP, Schams D, Berisha B, Pfaffl MW: Involvement of proinflammatory cytokines, mediators of inflammation, and basic fibroblast growth factor in prostaglandin F2α-induced luteolysis in bovine corpus luteum. Biol Reprod 2004, 70:473-480.
13. Michael AE, Abayasekara DR, Webley GE: Cellular mechanisms of luteolysis. Mol Cell Endocrinol 1994, 99:R1-R9.
14. Juengel JL, Garverick HA, Johnson AL, Youngquist RS, Smith MF: Apoptosis during luteal regression in cattle. Endocrinology 1993, 132:249-254.
15. Duncan WC, McNeilly AS, Illingworth PJ: The effect of luteal "rescue" on the expression and localization of matrix metalloproteinases and their tissue inhibitors in the human corpus luteum. J Clin Endocrinol Metab 1998, 83:2470-2478.
16. Ny T, Wahlberg P, Brändsröm IJ: Matrix remodeling in the ovary: regulation and functional role of the plasminogen activator and matrix metalloproteinase systems. Mol Cell Endocrinol 2002, 187:29-38.
17. Pitzel L, Ludemann S, Wuttke W: Secretion and gene expression of metalloproteinases and gene expression of their inhibitors in porcine corpora lutea at different stages of the luteal phase. Biol Reprod 2000, 62:1121-1127.
18. Boone DL, Yan W, Tsang BK: Identification of a deoxyribonuclease I-like endonuclease in rat granulosa and luteal cell nuclei. Biol Reprod 1995, 53:1057-1065.
19. Moscatelli D, Rifkin DB: Membrane and matrix localization of proteinases: a common theme in tumor cell invasion and angiogenesis. Biochim Biophys Acta 1988, 948:67-85.
20. Liotta LA, Steeg PS, Stetler-Stevenson WG: Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991, 64:327-336.
21. Goldberg MJ, Moses MA, Tsang PC: Identification of matrix metalloproteinases and metalloproteinase inhibitors in bovine corpora lutea and their variation during the estrous cycle. J Anim Sci 1996, 74:849-857.
22. Endo T, Aten RF, Wang F, Behrman HR: Coordinate induction and activation of metalloproteinase and ascorbate depletion in structural luteolysis. Endocrinology 1993, 133:690-698.
23. Li QL, Wang HM, Lin HY, Liu DL, Zhang X, Liu GY, Qian D, Zhu C: Expression of gelatinases and their tissue inhibitors in rat corpus luteum during pregnancy and postpartum. Mol Reprod Dev 2002, 63:273-281.
24. Tsang PC, Poff JP, Boulton EP, Condon WA: Four-day-old bovine corpus luteum: progesterone production and identification of matrix metalloproteinase activity in vitro. Biol Reprod 1995, 53:1160-1168.
25. Chen X, Gao H, Gao F, Wei P, Hu Z, Liu Y: Temporal and spatial expression of MMP-2, -9, -14 and their inhibitors TIMP-1, -2, -3 in the corpus luteum of the cycling rhesus monkey. Sci China C Life Sci 2006, 49:37-45.
26. Liu K, Wahlberg P, Hagglund AC, Ny T: Expression pattern and functional studies of matrix degrading proteases and their inhibitors in the mouse corpus luteum. Mol Cell Endocrinol 2003, 205:131-140.
27. Ricke WA, Smith GW, Reynolds LP, Redmer DA, Smith MF: Matrix metalloproteinase (2, 9, and 14) expression, localization, and activity in ovine corpora lutea throughout the estrous cycle. Biol Reprod 2002, 66:1083-1094.
28. Matrisian LM: Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 1990, 6:121-125.
29. Luck MR, Zhao Y: Structural remodelling of reproductive tissues. J Endocrinol 1995, 146:191-195.
30. Jablonka-Shariff A, Grazul-Bilska AT, Redmer DA, Reynolds LP: Growth and cellular proliferation of ovine corpora lutea throughout the estrous cycle. Endocrinology 1993, 133:1871-1879.
31. Luck MR, Zhao Y: Identification and measurement of collagen in the bovine corpus luteum and its relationship with ascorbic acid and tissue development. J Reprod Fertil 1993, 99:647-652.
32. Russell DL, Salamonsen LA, Findlay JK: Immunization against the N-terminal peptide of the inhibin α43-subunit (αN) disrupts tissue remodeling and the increase in matrix metalloproteinase-2 during ovulation. Endocrinology 1995, 136:3657-3664.
33. Zhao Y, Luck MR: Bovine granulosa cells express extracellular matrix proteins and their regulators during luteinization in culture. Reprod Fertil Dev 1996, 8:259-266.
34. Puistola U, Westerlund A, Kauppila A, Turpeenniemi-Hujanen T: Regulation of 72-kd type IV collagenase-matrix metalloproteinase-2 by estradiol and gonadotropin-releasing hormone agonist in human granulosa-lutein cells. Fertil Steril 1995, 64:81-87.
35. Berisha B, Schams D, Kosmann M, Amselgruber W, Einspanier R: Expression and tissue concentration of vascular endothelial growth factor, its receptors, and localization in the bovine corpus luteum during estrous cycle and pregnancy. Biol Reprod 2000, 63:1106-1114.
36. Redmer DA, Dai Y, Li J, Charnock-Jones DS, Smith SK, Reynolds LP, Moor RM: Characterization and expression of vascular endothelial growth factor (VEGF) in the ovine corpus luteum. J Reprod Fertil 1996, 108:157-165.
37. Al-zi'abi MO, Watson ED, Fraser HM: Angiogenesis and vascular endothelial growth factor expression in the equine corpus luteum. Reproduction 2003, 125:259-270.
38. Tesone M, Stouffer RL, Borman SM, Hennebold JD, Molskness TA: Vascular Endothelial Growth Factor (VEGF) production by the monkey corpus luteum during the menstrual cycle: isoform-selective mRNA expression in vivo and hypoxia-regulated protein secretion in vitro. Biol Reprod 2005, 73:927-934.
39. Boonyaprakob U, Gadsby JE, Hedgpeth V, Routh P, Almond GW: Expression and localization of vascular endothelial growth factor and its receptors in pig corpora lutea during the oestrous cycle. Reproduction 2003, 126:393-405.
40. Tang Y, Nakada MT, Rafferty P, Laraio J, McCabe FL, Millar H, Cunningham M, Snyder LA, Bugelski P, Yan L: Regulation of vascular endothelial growth factor expression by EMMPRIN via the PI3K-Akt signaling pathway. Mol Cancer Res 2006, 4:371-377.
41. Taraboletti G, D'Ascenzo S, Giusti I, Marchetti D, Borsotti P, Millimaggi D, Gavazzi R, Pavan A, Dolo V: Bioavailability of VEGF in tumor-shed vesicles depends on vesicle burst induced by acidic pH. Neoplasia 2006, 8:96-103.
42. Kaliski A, Maggiorella L, Cengel KA, Mathe D, Rouffiac V, Opolon P, Lassau N, Bourhis J, Deutsch E: Angiogenesis and tumor growth inhibition by a matrix metalloproteinase inhibitor targeting radiation-induced invasion. Mol Cancer Ther 2005, 4:1717-1728.
43. Lamy S, Ruiz MT, Wisniewski J, Garde S, Rabbani SA, Panchal C, Wu JJ, Annabi B: A prostate secretory protein94-derived synthetic peptide PCK3145 inhibits VEGF signalling in endothelial cells: implication in tumor angiogenesis. Int J Cancer 2006, 118:2350-2358.
44. Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, Tanzawa K, Thorpe P, Itohara S, Werb Z, Hanahan D: Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2000, 2:737-744.
45. Wang FQ, So J, Reierstad S, Fishman DA: Vascular endothelial growth factor-regulated ovarian cancer invasion and migration involves expression and activation of matrix metalloproteinases. Int J Cancer 2006, 118:879-888.
46. Wulff C, Dickson SE, Duncan WC, Fraser HM: Angiogenesis in the human corpus luteum: simulated early pregnancy by HCG treatment is associated with both angiogenesis and vessel stabilization. Hum Reprod 2001, 16:2515-2524.
47. Rowe AJ, Morris KD, Bicknell R, Fraser HM: Angiogenesis in the corpus luteum of early pregnancy in the marmoset and the effects of vascular endothelial growth factor immunoneutralization on establishment of pregnancy. Biol Reprod 2002, 67:1180-1188.
48. Pauli SA, Tang H, Wang J, Bohlen P, Posser R, Hartman T, Sauer MV, Kitajewski J, Zimmermann RC: The vascular endothelial growth factor (VEGF)/VEGF receptor 2 pathway is critical for blood vessel survival in corpora lutea of pregnancy in the rodent. Endocrinology 2005, 146:1301-1311.
49. Kashida S, Sugino N, Takiguchi S, Karube A, Takayama H, Yamagata Y, Nakamura Y, Kato H: Regulation and role of vascular endothelial growth factor in the corpus luteum during midpregnancy in rats. Biol Reprod 2001, 64:317-323.
50. ΔΔCt method. Methods 2001, 25:402-408.
51. ++ dependent endonuclease activity in rat granulosa and luteal cells. Endocrinology 1989, 125:2218-2220.
52. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 1951, 193:265-275.